Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Outlook 2025-2034: Market Share, and Growth Analysis By Test Type (Laboratory, Point Of Care Testing), By Product (Assays And Kits, Instruments Or Analyzers), By Technology, By End User

The Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market is valued at USD 2.6 billion in 2025 and is projected to grow at a CAGR of 11.6% to reach USD 7 billion by 2034. The Chl... もっと見る

出版社	出版年月	電子版価格	納期	言語
OG Analysis オージーアナリシス	2025年10月16日	US$3,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	通常3-4営業日以内	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

Table of Contents

Summary

The Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market is valued at USD 2.6 billion in 2025 and is projected to grow at a CAGR of 11.6% to reach USD 7 billion by 2034.

The Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) testing market is a crucial segment of the diagnostic industry, addressing the global burden of two of the most common sexually transmitted infections (STIs). Chlamydia and gonorrhea, caused by bacterial pathogens, can lead to severe reproductive health issues if left untreated, including infertility and ectopic pregnancy. Early detection through effective testing methods is essential for controlling the spread of these infections and ensuring timely treatment. The market is characterized by a diverse array of testing solutions, including nucleic acid amplification tests (NAATs), rapid point-of-care (POC) tests, and traditional culture-based assays.

Recent advances in molecular diagnostics have significantly enhanced the sensitivity, specificity, and speed of CT and NG testing. NAATs have become the gold standard for detection due to their ability to identify infections with high accuracy, even in asymptomatic individuals. The development of multiplex assays that simultaneously detect multiple STIs has streamlined laboratory workflows and reduced turnaround times. In addition, the growing availability of POC tests in low-resource settings has expanded access to diagnostic services, particularly in regions where laboratory infrastructure is limited. As a result, the market continues to grow, driven by increasing awareness, improved healthcare access, and rising adoption of advanced diagnostic technologies.

Despite these advancements, the market faces several challenges. Affordability and accessibility remain significant barriers in low- and middle-income countries, where the prevalence of these infections is often highest. Additionally, the emergence of antibiotic-resistant strains of Neisseria gonorrhoeae has added complexity to diagnosis and treatment, necessitating ongoing research and development. As stakeholders work to address these challenges, the CT and NG testing market is poised for further innovation and expansion, helping to reduce the global burden of these prevalent STIs.

Key Insights_ Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market

1. Increasing adoption of multiplex assays for simultaneous detection of CT, NG, and other STIs.
2. Expansion of point-of-care testing options in low-resource and remote settings.
3. Development of resistance detection assays to identify antibiotic-resistant Neisseria gonorrhoeae strains.
4. Growing use of self-sampling kits and telemedicine solutions to improve access to testing.
5. Integration of molecular diagnostic platforms into routine STI screening programs.

1. Rising prevalence of STIs globally, increasing demand for accurate and rapid testing solutions.
2. Growing awareness of sexual health and the importance of early detection.
3. Technological advancements in molecular diagnostics and point-of-care testing.
4. Government and non-government initiatives to expand STI screening programs and improve healthcare access.

1. High costs of advanced diagnostic tests, limiting accessibility in low-income regions.
2. Emerging antibiotic-resistant Neisseria gonorrhoeae strains complicating diagnosis and treatment.
3. Inconsistent screening guidelines and varying levels of healthcare infrastructure worldwide.

Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Segmentation

By Test Type

Laboratory

Point Of Care Testing

By Product

Assays And Kits

Instruments Or Analyzers

By Technology

Isothermal Nucleic Acid Amplification Technology

Polymerase Chain Reaction

Immunodiagnostics

Other Technologies

By End User

Diagnostic Laboratories

Hospitals And Clinics

Other End Users

Key Companies Analysed

F. Hoffmann-La Roche AG

Thermo Fisher Scientific

Abbott Laboratories

Danaher Corporation

Merck KGaA

Siemens Healthineers

Becton Dickinson and Company

Grifols SA

Hologic Inc.

PerkinElmer

bioMérieux

Sysmex Corporation

Bio-Rad Laboratories

QIAGEN

Quidel Corporation

DiaSorin

Cepheid

Seegene Inc.

Meridian Bioscience Inc.

Sekisui Diagnostics

J. Mitra & Co. Pvt. Ltd.

Atlas Medical

Hardy Diagnostics

Molbio Diagnostics Pvt. Ltd.

NG Biotech

Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Analytics

The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modeling, to assess supply–demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends. Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behavior are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Competitive Intelligence

The competitive landscape is mapped through OG Analysis’ proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption. Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.

Countries Covered

North America — Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing market data and outlook to 2034
- United States
- Canada
- Mexico
Europe — Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- BeNeLux
- Russia
- Sweden
Asia-Pacific — Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
Middle East and Africa — Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
South and Central America — Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru

* We can include data and analysis of additional countries on demand.

Research Methodology

This study combines primary inputs from industry experts across the Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

Key Questions Addressed

What is the current and forecast market size of the Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing industry at global, regional, and country levels?

Which types, applications, and technologies present the highest growth potential?

How are supply chains adapting to geopolitical and economic shocks?

What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?

Who are the leading players, and how are their strategies evolving in the face of global uncertainty?

Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?

Where are the most investable opportunities—across technology roadmaps, sustainability-linked innovation, and M&A—and what is the best segment to invest over the next 3–5 years?

Your Key Takeaways from the Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Report

Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing market size and growth projections (CAGR), 2024-2034
Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing trade, costs, and supply chains
Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing market size, share, and outlook across 5 regions and 27 countries, 2023-2034
Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
Short- and long-term Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing market trends, drivers, restraints, and opportunities
Porter’s Five Forces analysis, technological developments, and Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing supply chain analysis
Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing trade analysis, Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing market price analysis, and Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing supply/demand dynamics
Profiles of 5 leading companies—overview, key strategies, financials, and products
Latest Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing market news and developments

Additional Support

With the purchase of this report, you will receive

An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
Complimentary report update to incorporate the latest available data and the impact of recent market developments.

* The updated report will be delivered within 3 working days

ページTOPに戻る

1. Table of Contents
1.1 List of Tables
1.2 List of Figures

2. Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Summary, 2025
2.1 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Industry Overview
2.1.1 Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Revenues (In US$ billion)
2.2 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Scope
2.3 Research Methodology

3. Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Insights, 2024-2034
3.1 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Drivers
3.2 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Restraints
3.3 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Opportunities
3.4 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Challenges
3.5 Tariff Impact on Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Supply Chain Patterns

4. Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Analytics
4.1 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size and Share, Key Products, 2025 Vs 2034
4.2 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size and Share, Dominant Applications, 2025 Vs 2034
4.3 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size and Share, Leading End Uses, 2025 Vs 2034
4.4 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size and Share, High Growth Countries, 2025 Vs 2034
4.5 Five Forces Analysis for Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market
4.5.1 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Industry Attractiveness Index, 2025
4.5.2 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Supplier Intelligence
4.5.3 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Buyer Intelligence
4.5.4 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Competition Intelligence
4.5.5 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Product Alternatives and Substitutes Intelligence
4.5.6 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Entry Intelligence

5. Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Statistics – Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2034
5.1 World Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Potential and Growth Outlook, 2024- 2034 ($ billion)
5.1 Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Sales Outlook and CAGR Growth By Test Type, 2024- 2034 ($ billion)
5.2 Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Sales Outlook and CAGR Growth By Product, 2024- 2034 ($ billion)
5.3 Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Sales Outlook and CAGR Growth By Technology, 2024- 2034 ($ billion)
5.4 Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Sales Outlook and CAGR Growth By End User, 2024- 2034 ($ billion)
5.5 Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Sales Outlook and Growth by Region, 2024- 2034 ($ billion)

6. Asia Pacific Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Industry Statistics – Market Size, Share, Competition and Outlook
6.1 Asia Pacific Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Insights, 2025
6.2 Asia Pacific Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Revenue Forecast By Test Type, 2024- 2034 (USD billion)
6.3 Asia Pacific Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Revenue Forecast By Product, 2024- 2034 (USD billion)
6.4 Asia Pacific Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Revenue Forecast By Technology, 2024- 2034 (USD billion)
6.5 Asia Pacific Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Revenue Forecast By End User, 2024- 2034 (USD billion)
6.6 Asia Pacific Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Revenue Forecast by Country, 2024- 2034 (USD billion)
6.6.1 China Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Opportunities, Growth 2024- 2034
6.6.2 India Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Opportunities, Growth 2024- 2034
6.6.3 Japan Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Opportunities, Growth 2024- 2034
6.6.4 Australia Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Opportunities, Growth 2024- 2034

7. Europe Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Data, Penetration, and Business Prospects to 2034
7.1 Europe Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Key Findings, 2025
7.2 Europe Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size and Percentage Breakdown By Test Type, 2024- 2034 (USD billion)
7.3 Europe Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size and Percentage Breakdown By Product, 2024- 2034 (USD billion)
7.4 Europe Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size and Percentage Breakdown By Technology, 2024- 2034 (USD billion)
7.5 Europe Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size and Percentage Breakdown By End User, 2024- 2034 (USD billion)
7.6 Europe Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size and Percentage Breakdown by Country, 2024- 2034 (USD billion)
7.6.1 Germany Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Trends, Growth Outlook to 2034
7.6.2 United Kingdom Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Trends, Growth Outlook to 2034
7.6.2 France Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Trends, Growth Outlook to 2034
7.6.2 Italy Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Trends, Growth Outlook to 2034
7.6.2 Spain Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Trends, Growth Outlook to 2034

8. North America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Growth Trends, and Future Prospects to 2034
8.1 North America Snapshot, 2025
8.2 North America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Analysis and Outlook By Test Type, 2024- 2034 ($ billion)
8.3 North America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Analysis and Outlook By Product, 2024- 2034 ($ billion)
8.4 North America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Analysis and Outlook By Technology, 2024- 2034 ($ billion)
8.5 North America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Analysis and Outlook By End User, 2024- 2034 ($ billion)
8.6 North America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Analysis and Outlook by Country, 2024- 2034 ($ billion)
8.6.1 United States Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Share, Growth Trends and Forecast, 2024- 2034
8.6.1 Canada Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Share, Growth Trends and Forecast, 2024- 2034
8.6.1 Mexico Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Share, Growth Trends and Forecast, 2024- 2034

9. South and Central America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Drivers, Challenges, and Future Prospects
9.1 Latin America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Data, 2025
9.2 Latin America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Future By Test Type, 2024- 2034 ($ billion)
9.3 Latin America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Future By Product, 2024- 2034 ($ billion)
9.4 Latin America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Future By Technology, 2024- 2034 ($ billion)
9.5 Latin America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Future By End User, 2024- 2034 ($ billion)
9.6 Latin America Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Future by Country, 2024- 2034 ($ billion)
9.6.1 Brazil Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Share and Opportunities to 2034
9.6.2 Argentina Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Size, Share and Opportunities to 2034

10. Middle East Africa Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Outlook and Growth Prospects
10.1 Middle East Africa Overview, 2025
10.2 Middle East Africa Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Statistics By Test Type, 2024- 2034 (USD billion)
10.3 Middle East Africa Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Statistics By Product, 2024- 2034 (USD billion)
10.4 Middle East Africa Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Statistics By Technology, 2024- 2034 (USD billion)
10.5 Middle East Africa Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Statistics By Technology, 2024- 2034 (USD billion)
10.6 Middle East Africa Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Statistics by Country, 2024- 2034 (USD billion)
10.6.1 Middle East Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Value, Trends, Growth Forecasts to 2034
10.6.2 Africa Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Value, Trends, Growth Forecasts to 2034

11. Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Structure and Competitive Landscape
11.1 Key Companies in Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Industry
11.2 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Business Overview
11.3 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Product Portfolio Analysis
11.4 Financial Analysis
11.5 SWOT Analysis

12 Appendix
12.1 Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Market Volume (Tons)
12.1 Global Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Trade and Price Analysis
12.2 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Parent Market and Other Relevant Analysis
12.3 Publisher Expertise
12.2 Chlamydia Trachomatis (Ct) And Neisseria Gonorrhoeae (Ng) Testing Industry Report Sources and Methodology

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（通信・IT）の最新刊レポート

OG Analysis社の情報技術・メディア分野での最新刊レポート

本レポートと同じKEY WORD（laboratory）の最新刊レポート

よくあるご質問

OG Analysis社はどのような調査会社ですか?

OG Analysisは、10年以上の専門知識を持ち、半導体、エネルギー、化学品、自動車、農業など多様な市場調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行っています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。